The fusion of Toxoplasma gondii SAG1 vaccine candidate to Leishmania infantum heat shock protein 83-kDa improves expression levels in tobacco chloroplasts

Biotechnology Journal

Volumn 10, Issue 5, 2015, Pages 748-759

  Albarracín, Romina M ^a   Becher, Melina Laguía ^a   Farran, Inmaculada ^b   Sander, Valeria A ^a   Corigliano, Mariana G ^a   Yácono, María L ^a   Pariani, Sebastián ^a   López, Edwin Sánchez ^a   Veramendi, Jon ^b   Clemente, Marina ^a  

^a INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^b PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

Chloroplast transformation; Hsp83; Leishmania infantum; SAG1; Toxoplasma gondii

Indexed keywords

ANTIGENS; RECOMBINANT PROTEINS; TOBACCO; VACCINES;

CHLOROPLAST TRANSFORMATION; HSP83; LEISHMANIA INFANTUM; SAG1; TOXOPLASMA GONDII;

PROTEINS;

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 83; HEAT SHOCK PROTEIN 90; HYBRID PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN P53; TOXOPLASMA GONDII SAG1 VACCINE; TOXOPLASMA GONDII VACCINE; UNCLASSIFIED DRUG; HSP83 PROTEIN, PROTOZOAN; PARASITE ANTIGEN; PROTOZOAL PROTEIN; PROTOZOAL VACCINE; PROTOZOON ANTIBODY; SAG1 ANTIGEN, TOXOPLASMA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGENICITY; ARTICLE; BRAIN CYST; CHLOROPLAST; CHLOROPLAST DIVISION; CHLOROPLAST GENOME; CONTROLLED STUDY; FEMALE; FRESH WEIGHT; GENE EXPRESSION SYSTEM; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; LEAF AGE; LEISHMANIA INFANTUM; MOUSE; NICOTIANA TABACUM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SEED PRODUCTION; TOBACCO; TOXOPLASMA GONDII; TOXOPLASMOSIS; ANIMAL; BIOSYNTHESIS; GENETIC TRANSFORMATION; GENETICS; IMMUNOLOGY; METABOLISM; VACCINATION;

LEISHMANIA INFANTUM; NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM; TOXOPLASMA GONDII;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHLOROPLASTS; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEISHMANIA INFANTUM; MICE; PROTOZOAN PROTEINS; PROTOZOAN VACCINES; RECOMBINANT FUSION PROTEINS; TOBACCO; TRANSFORMATION, GENETIC; VACCINATION;

EID: 84928825317     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201400742     Document Type: Article

References (60)

1. Makhzoum, A., Benyammi, R., Moustafa, K., Trémouillaux-Guiller, J., Recent advances on host plants and expression cassettes' structure and function in plant molecular pharming. BioDrugs 2014, 28, 145-159.
2. Melnik, S., Stoger, E., Green factories for biopharmaceuticals. Curr. Med. Chem. 2013, 20, 1038-1046.
3. Twyman, R. M., Schillberg, S., Fischer, R., Optimizing the yield of recombinant pharmaceutical proteins in plants. Curr. Pharm. Des. 2013, 19, 5486-5494.
4. Khan, I., Twyman, R. M., Arcalis, E., Stoger, E., Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechnol. J. 2012, 7, 1099-1108.
5. Scotti, N., Rigano, M. M., Cardi, T., Production of foreign proteins using plastid transformation. Biotechnol. Adv. 2012, 30, 387-397.
6. Bock, R., Genetic engineering of the chloroplast: novel tools and new applications. Curr. Opin. Biotechnol. 2014, 26, 7-13.
7. Birch-Machin, I., Newell, C. A., Hibberd, J. M., Gray, J. C., Accumulation of rotavirus VP6 protein in chloroplasts of transplastomic tobacco is limited by protein stability. Plant Biotechnol. J. 2004, 2, 261-270.
8. Wirth, S., Segretin, M. E., Mentaberry, A., Bravo-Almonacid, F., Accumulation of hEGF and hEGF-fusion proteins in chloroplast-transformed tobacco plants is higher in the dark than in the light. J. Biotechnol. 2006, 125, 159-172.
9. Tissot, G., Canard, H., Nadai, M., Martone, A. et al., Translocation of aprotinin, a therapeutic protease inhibitor, into the thylakoid lumen of genetically engineered tobacco chloroplasts. Plant Biotechnol. J. 2008, 6, 309-320.
10. De Marchis, F., Pompa, A., Mannucci, R., Morosinotto, T. et al., A plant secretory signal peptide targets plastome-encoded recombinant proteins to the thylakoid membrane. Plant Mol. Biol. 2011, 76, 427-441.
11. Del L Yácono, M., Farran, I., Becher, M. L., Sander, V. et al., A chloroplast-derived Toxoplasma gondii GRA4 antigen used as an oral vaccine protects against toxoplasmosis in mice. Plant Biotechnol. J. 2012, 10, 1136-1144.
12. Lekutis, C., Ferguson, D. J., Grigg, M. E., Camps, M. et al., Surface antigens of Toxoplasma gondii: variations on a theme. Int. J. Parasitol. 2001, 31, 1285-1292.
13. Bout, D. T., Mevelec, M. N., Velge-Roussel, F., Dimier-Poisson, I. et al., Prospects for a human Toxoplasma vaccine. Curr. Drug Targets Immune Endocr. Metabol. Disord. 2002, 2, 227-234.
14. Rorman, E., Zamir, C. S., Rilkis, I., Ben-David, H., Congenital toxoplasmosis - prenatal aspects of Toxoplasma gondii infection. Reprod. Toxicol. 2006, 21, 458-472.
15. Petersen, E., Nielsen, H. V., Christiansen, L., Spenter, J., Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 1998, 16, 1283-1289.
16. Chen, G., Chen, H., Guo, H., Zheng, H., Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice. Chin. Med. J. (Engl) 2002, 115, 1448-1452.
17. Couper, K.N., Nielsen, H.V., Petersen, E., Roberts, F. et al., DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 2003, 21, 2813-2820.
18. Zhou, H., Gu, Q., Zhao, Q., Zhang, J. et al., Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris. Parasitol. Res. 2007, 100, 829-835.
19. Qu, D., Wang, S., Cai, W., Du, A., Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vaccine 2008, 26, 4541-4548.
20. Li, W. S., Chen, Q. X., Ye, J. X., Xie, Z. X. et al., Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses. Parasitol. Res. 2011, 109, 637-644.
21. Dziadek, B., Gatkowska, J., Brzostek, A., Dziadek, J. et al., Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Vaccine 2011, 29, 821-830.
22. Burg, J.L., Perelman, D., Kasper, L.H., Ware, P.L. et al., Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J. Immunol. 1988, 141, 3584-3591.
23. Makioka, A., Kobayashi, A., Toxoplasmacidal activity of macrophages activated by recombinant major surface antigen (P30) of Toxoplasma gondii. Infect. Immun. 1991, 59, 2851-2852.
24. Harning, D., Spenter, J., Metsis, A., Vuust, J. et al., Recombinant Toxoplasma gondii surface antigen 1 (P30) expressed in Escherichia coli is recognized by human Toxoplasma-specific immunoglobulin M (IgM) and IgG antibodies. Clin. Diagn. Lab. Immunol. 1996, 3, 355-357.
25. Nigro, M., Gutierrez, A., Hoffer, A. M., Clemente, M. et al., Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagn. Microbiol. Infect. Dis. 2003, 47, 609-613.
26. Clemente, M., Curilovic, R., Sassone, A., Zelada, A. et al., Production of the main surface antigen of Toxoplasma gondii in tobacco leaves and analysis of its antigenicity and immunogenicity. Mol. Biotechnol. 2005, 30, 41-50.
27. Laguía-Becher, M., Martín, V., Kraemer, M., Corigliano, M. et al., Effect of codon optimization and subcellular targeting on Toxoplasma gondii antigen SAG1 expression in tobacco leaves to use in subcutaneous and oral immunization in mice. BMC Biotechnol. 2010, 10, 52.
28. Pearl, L. H., Prodromou, C., Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu. Rev. Biochem. 2006, 75, 271-294.
29. Miernyk, J. A., Protein Folding in the Plant Cell. Plant Physiol. 1999, 121, 695-703.
30. Picard, D., Heat-shock protein 90 a chaperone for folding and regulation. Cell Mol. Life Sci. 2002, 59, 1640-1648.
31. Yabe, N., Takahashi, T., Komeda, Y., Analysis of tissue-specific expression of Arabidopsis thaliana HSP90-family gene HSP81. Plant Cell Physiol. 1994, 35, 1207-1219.
32. Echeverria, P. C., de Miguel, N., Costas, M., Angel, S. O., Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein. Vaccine 2006, 24, 4102-4110.
33. Cóceres, V. M., Becher, M. L., De Napoli, M. G., Corvi, M. M. et al., Evaluation of the antigenic value of recombinant Toxoplasma gondii HSP20 to detect specific immunoglobulin G antibodies in Toxoplasma infected humans. Exp. Parasitol. 2010, 126, 263-266.
34. Farran, I., McCarthy-Suárez, I., Río-Manterola, F., Mansilla, C. et al., The vaccine adjuvant extra domain A from fibronectin retains its proinflammatory properties when expressed in tobacco chloroplasts. Planta 2010, 231, 977-990.
35. Ortigosa, S. M., Fernández-San Millán, A., Veramendi, J., Stable production of peptide antigens in transgenic tobacco chloroplasts by fusion to the p53 tetramerisation domain. Transgenic Res. 2010, 19, 703-709.
36. Rico, A., Angel, S. O., Alonso, C., Requena, J. M., Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83. Mol. Immunol. 1999, 36, 1131-1139.
37. Daniell, H., Transformation and foreign gene expression in plants by microprojectile bombardment. Methods Mol. Biol. 1997, 62, 463-489.
38. Fernández-San Millán, A., Farran, I., Molina, A., Mingo-Castel, A. M. et al., Expression of recombinant proteins lacking methionine as N-terminal amino acid in plastids: human serum albumin as a case study. J. Biotechnol. 2007, 127, 593-604.
39. Angel, S. O., Requena, J. M., Soto, M., Criado, D. et al., During canine leishmaniasis a protein belonging to the 83-kDa heat-shock protein family elicits a strong humoral response. Acta Trop. 1996, 62, 45-56.
40. Ye, G. N., Hajdukiewicz, P. T., Broyles, D., Rodriguez, D. et al., Plastid-expressed 5-enolpyruvylshikimate-3-phosphate synthase genes provide high level glyphosate tolerance in tobacco. Plant J. 2001, 25, 261-270.
41. Molina, A., Hervás-Stubbs, S., Daniell, H., Mingo-Castel, A. M. et al., High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol. J. 2004, 2, 141-153.
42. Wang, Y., Yin, H., Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii. Parasit. Vectors 2014, 7, 180.
43. Biemans, R., Grégoire, D., Haumont, M., Bosseloir, A. et al., The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation. J. Biotechnol. 1998, 66, 137-146.
44. Letourneur, O., Gervasi, G., Gaïa, S., Pagès, J. et al., Characterization of Toxoplasma gondii surface antigen 1 (SAG1) secreted from Pichia pastoris: evidence of hyper O-glycosylation. Biotechnol. Appl. Biochem. 2001, 33, 35-45.
45. Kim, K., Bülow, R., Kampmeier, J., Boothroyd, J. C., Conformationally appropriate expression of the Toxoplasma antigen SAG1 (p30) in CHO cells. Infect. Immun. 1994, 62, 203-209.
46. Scotti, N., Cardi, T., Transgene-induced pleiotropic effects in transplastomic plants. Biotechnol. Lett. 2014, 36, 229-239.
47. Cao, D., Froehlich, J. E., Zhang, H., Cheng, C. L., The chlorate-resistant and photomorphogenesis-defective mutant cr88 encodes a chloroplast-targeted HSP90. Plant J. 2003, 33, 107-118.
48. Feng, J., Fan, P., Jiang, P., Lv, S. et al., Chloroplast-targeted Hsp90 plays essential roles in plastid development and embryogenesis in Arabidopsis possibly linking with VIPP1. Physiol. Plant 2014, 150, 292-307.
49. Bellucci, M., De Marchis, F., Nicoletti, I., Arcioni, S., Zeolin is a recombinant storage protein with different solubility and stability properties according to its localization in the endoplasmic reticulum or in the chloroplast. J. Biotechnol. 2007, 131, 97-105.
50. Staub, J. M., Garcia, B., Graves, J., Hajdukiewicz, P. T. et al., High-yield production of a human therapeutic protein in tobacco chloroplasts. Nat. Biotechnol. 2000, 18, 333-338.
51. Bally, J., Job, C., Belghazi, M., Job, D., Metabolic adaptation in transplastomic plants massively accumulating recombinant proteins. PLoS One 2011, 6, e25289.
52. Oey, M., Lohse, M., Kreikemeyer, B., Bock, R., Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J. 2009, 57, 436-445.
53. Johnson, J. L., Evolution and function of diverse Hsp90 homologs and cochaperone proteins. Biochim. Biophys Acta 2012, 1823, 607-613.
54. Eckl, J. M., Richter, K. Functions of the Hsp90 chaperone system: lifting client proteins to new heights. Int. J. Biochem. Mol. Biol. 2013, 4, 157-165.
55. Sanz-Barrio, R., Fernandez-San Millan, A., Carballeda, J., Corral-Martinez, P. et al., Chaperone-like properties of tobacco plastid thioredoxins f and m. J. Exp. Bot. 2012, 63, 365-379.
56. Sanz-Barrio, R., Fernandez-San Millan, A., Corral-Martinez, P., Segui-Simarro, J. M. et al., Tobacco plastidial thioredoxins as modulators of recombinant protein production in transgenic chloroplasts. Plant Biotechnol. J. 2011, 9, 639-650.
57. Velge-Roussel, F., Chardès, T., Mévélec, P., Brillard, M. et al., Epitopic analysis of the Toxoplasma gondii major surface antigen SAG1. Mol. Biochem. Parasitol. 1994, 66, 31-38.
58. Velmurugan, G. V., Tewari, A. K., Rao, J. R., Baidya, S. et al., High-level expression of SAG1 and GRA7 gene of Toxoplasma gondii (Izatnagar isolate) and their application in serodiagnosis of goat toxoplasmosis. Vet. Parasitol. 2008, 154, 185-192.
59. Cardona, N., de-la-Torre, A., Siachoque, H., Patarroyo, M. A. et al., Toxoplasma gondii: P30 peptides recognition pattern in human toxoplasmosis. Exp. Parasitol. 2009, 123, 199-202.
60. Siachoque, H., Guzman, F., Burgos, J., Patarroyo, M. E. et al., Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Exp. Parasitol. 2006, 114, 62-65.